KR880013928A - 신규 5-테트라히드로푸란 및 테트라 히드로티오펜 - Google Patents

신규 5-테트라히드로푸란 및 테트라 히드로티오펜

Info

Publication number
KR880013928A
KR880013928A KR1019880006343A KR880006343A KR880013928A KR 880013928 A KR880013928 A KR 880013928A KR 1019880006343 A KR1019880006343 A KR 1019880006343A KR 880006343 A KR880006343 A KR 880006343A KR 880013928 A KR880013928 A KR 880013928A
Authority
KR
South Korea
Prior art keywords
tetrahydrothiophene
tetrahydrofuran
new
Prior art date
Application number
KR1019880006343A
Other languages
English (en)
Other versions
KR960005152B1 (ko
Inventor
쟈끄 고드프트와 쟝
에망 프랑소와즈
브라케 삐에르
Original Assignee
소시에떼 드 꽁세이으 드 르셰르셰 에 다쁠리까시옹 시앙띠피끄
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 소시에떼 드 꽁세이으 드 르셰르셰 에 다쁠리까시옹 시앙띠피끄 filed Critical 소시에떼 드 꽁세이으 드 르셰르셰 에 다쁠리까시옹 시앙띠피끄
Publication of KR880013928A publication Critical patent/KR880013928A/ko
Application granted granted Critical
Publication of KR960005152B1 publication Critical patent/KR960005152B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019880006343A 1987-05-29 1988-05-28 신규 5-(ω-암모니아실옥시메틸렌)테트라히드로푸란 및 테트라 히드로티오펜 KR960005152B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878712693A GB8712693D0 (en) 1987-05-29 1987-05-29 Tetrahydrofurans etc
GB87-12693 1987-05-29

Publications (2)

Publication Number Publication Date
KR880013928A true KR880013928A (ko) 1988-12-22
KR960005152B1 KR960005152B1 (ko) 1996-04-22

Family

ID=10618139

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880006343A KR960005152B1 (ko) 1987-05-29 1988-05-28 신규 5-(ω-암모니아실옥시메틸렌)테트라히드로푸란 및 테트라 히드로티오펜

Country Status (32)

Country Link
US (1) US5017588A (ko)
JP (1) JPH0631228B2 (ko)
KR (1) KR960005152B1 (ko)
AR (1) AR243885A1 (ko)
AT (1) AT395715B (ko)
AU (1) AU610789B2 (ko)
BE (1) BE1002146A3 (ko)
CA (1) CA1317959C (ko)
CH (1) CH674985A5 (ko)
DE (1) DE3818106A1 (ko)
DK (1) DK167532B1 (ko)
ES (1) ES2009924A6 (ko)
FI (1) FI89353C (ko)
FR (2) FR2615854B1 (ko)
GB (2) GB8712693D0 (ko)
GR (1) GR1000147B (ko)
HK (1) HK101790A (ko)
IE (1) IE61341B1 (ko)
IN (1) IN168799B (ko)
IT (1) IT1219698B (ko)
LU (1) LU87229A1 (ko)
MA (1) MA21289A1 (ko)
MY (1) MY103289A (ko)
NL (1) NL192203C (ko)
NO (1) NO170086C (ko)
NZ (1) NZ224775A (ko)
OA (1) OA08878A (ko)
PT (1) PT87585B (ko)
SE (1) SE466449B (ko)
SG (1) SG93790G (ko)
TN (1) TNSN88049A1 (ko)
ZA (1) ZA883731B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8701727D0 (en) * 1987-01-27 1987-03-04 Scras Tetrahydrofuran derivatives
GB8712694D0 (en) * 1987-05-29 1987-07-01 Scras Tetrahydrofurans etc
ES2010568A6 (es) * 1988-08-04 1989-11-16 Uriach & Cia Sa J Procedimiento para la obtencion de derivados 2,5-disustituidos de tetrahidrofurano.
ES2013834A6 (es) * 1989-01-30 1990-06-01 Uriach & Cia Sa J Procedimiento para la obtencion de derivados 4-sustituidos de 2-alcoxitetrahidrofurano.
US5118708A (en) * 1989-06-23 1992-06-02 Norwich Eaton Pharmaceuticals, Inc. Use of 5-phenyl-2-furan esters, amides and ketones as neuroprotective agents
US20110097352A9 (en) * 1992-01-29 2011-04-28 Pharmexa Inc. Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
KR100326276B1 (ko) * 1999-12-14 2002-03-08 정명식 테트라하이드로푸란 유도체, 이의 제조방법 및 이를포함하는 항진균제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1088880A (en) * 1964-11-18 1967-10-25 Vantorex Ltd ª‡-cycloalkyleneimino-substituted esters
GB8701727D0 (en) * 1987-01-27 1987-03-04 Scras Tetrahydrofuran derivatives
GB8712694D0 (en) * 1987-05-29 1987-07-01 Scras Tetrahydrofurans etc

Also Published As

Publication number Publication date
NL8801315A (nl) 1988-12-16
ATA140788A (de) 1992-07-15
FR2615735B1 (fr) 1991-01-11
LU87229A1 (fr) 1988-12-13
DK291088D0 (da) 1988-05-27
JPS649988A (en) 1989-01-13
NO882335D0 (no) 1988-05-27
FI882475A0 (fi) 1988-05-26
GB2205100A (en) 1988-11-30
IT8820773A0 (it) 1988-05-27
BE1002146A3 (fr) 1990-07-31
TNSN88049A1 (fr) 1990-07-10
US5017588A (en) 1991-05-21
OA08878A (fr) 1989-10-31
IN168799B (ko) 1991-06-08
KR960005152B1 (ko) 1996-04-22
ZA883731B (en) 1989-02-22
NO170086B (no) 1992-06-01
HK101790A (en) 1990-12-14
NO882335L (no) 1988-11-30
FI882475A (fi) 1988-11-30
GR1000147B (el) 1991-09-27
AR243885A1 (es) 1993-09-30
GR880100342A (en) 1989-02-23
IE61341B1 (en) 1994-11-02
MY103289A (en) 1993-05-29
MA21289A1 (fr) 1988-12-31
IT1219698B (it) 1990-05-24
NO170086C (no) 1992-09-09
CA1317959C (en) 1993-05-18
SG93790G (en) 1991-01-18
CH674985A5 (ko) 1990-08-15
AT395715B (de) 1993-02-25
NZ224775A (en) 1990-01-29
FR2615854A1 (fr) 1988-12-02
FI89353C (fi) 1993-09-27
GB8712693D0 (en) 1987-07-01
FR2615854B1 (fr) 1990-12-28
FR2615735A1 (fr) 1988-12-02
AU1672288A (en) 1988-12-01
PT87585A (pt) 1989-05-31
NL192203B (nl) 1996-11-01
DE3818106C2 (ko) 1993-07-01
AU610789B2 (en) 1991-05-23
IE881599L (en) 1988-11-29
DK291088A (da) 1988-11-30
GB2205100B (en) 1990-08-15
GB8812488D0 (en) 1988-06-29
DK167532B1 (da) 1993-11-15
SE8801964D0 (sv) 1988-05-26
SE8801964L (sv) 1988-11-30
FI89353B (fi) 1993-06-15
PT87585B (pt) 1992-09-30
SE466449B (sv) 1992-02-17
JPH0631228B2 (ja) 1994-04-27
ES2009924A6 (es) 1989-10-16
DE3818106A1 (de) 1988-12-15
NL192203C (nl) 1997-03-04

Similar Documents

Publication Publication Date Title
ATA901789A (de) Somatostatinpeptid
ATA900689A (de) Calcitoninpeptide
DK348289D0 (da) Forbindelser
ATA172889A (de) Furanderivate
LV10019A (lv) Herbicida sastavs
DK70989A (da) Elektrode
KR880013928A (ko) 신규 5-테트라히드로푸란 및 테트라 히드로티오펜
FI91488B (fi) Seula
IS3470A7 (is) Rafskaut
DK84589D0 (da) Ekspressionsvektor
ATA140688A (de) Neue 5-methoxyalkylammoniumtetrahydrofurane und -tetrahydrothiophene
KR890021603U (ko) 바둑 교습구
SE8702354D0 (sv) Ny morfolinoenantiomer
SE8802591D0 (sv) Ny morfolinoenantiomer
BR8800408A (pt) Jogo
BR8805802A (pt) Jogo
BR8804648A (pt) Jogo trimino
BR8803614A (pt) Jogo recreativo
DK428987D0 (da) En fallelaas
SE8800664D0 (sv) Sikt
DK595788A (da) Ekspressionsvektor
ES1003490Y (es) Nueva chimenea-hogar
ES1001684Y (es) Nueva bolsa-contenedor
BR6802819U (pt) Regua pupilometrica
BR8806920A (pt) Quebra-cabeca

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee